|
2022-09-06 |
2022-09-01 |
S
Sale
|
Chief Financial Officer
Officer
|
34,571
+7.3%
394.12
US$4,574,155
|
34,571
+7.3%
|
394.12
|
US$4,574,155
|
|
|
2022-08-19 |
2022-08-18 |
S
Sale
|
See Remarks
Officer
|
29,455
+48.9%
271.16
US$2,899,150
|
29,455
+48.9%
|
271.16
|
US$2,899,150
|
|
|
2022-06-22 |
2022-06-21 |
PlS
Planned sale
|
Non-Executive Director
|
64,717
+10.9%
495.57
US$2,490,776
|
64,717
+10.9%
|
495.57
|
US$2,490,776
|
|
|
2022-06-22 |
2022-06-21 |
PlS
Planned sale
|
Non-Executive Director
|
1,908
-26.2%
27.24
US$51,983
|
1,908
-26.2%
|
27.24
|
US$51,983
|
|
|
2021-06-21 |
2021-06-18 |
PlS
Planned sale
|
Non-Executive Director
|
1,609
-30.4%
36.54
US$58,793
|
1,609
-30.4%
|
36.54
|
US$58,793
|
|
|
2021-05-10 |
2021-05-10 |
B
Purchase
|
Chief Human Resources Officer
Officer
|
500
+10.7%
37.96
US$18,980
|
500
+10.7%
|
37.96
|
US$18,980
|
|
|
2020-10-07 |
2020-10-05 |
PlS
Planned sale
|
Chief Human Resources Officer
Officer
|
4,532
-100.0%
60.00
US$271,920
|
4,532
-100.0%
|
60.00
|
US$271,920
|
|
|
2020-08-24 |
2020-08-20 |
S
Sale
|
Chief Scientific Officer
Officer
|
2,200
-29.6%
63.77
US$140,294
|
2,200
-29.6%
|
63.77
|
US$140,294
|
|
|
2020-08-07 |
2020-08-05 |
PlS
Planned sale
|
Chief Human Resources Officer
Officer
|
950
-100.0%
70.10
US$66,596
|
950
-100.0%
|
70.10
|
US$66,596
|
|
|
2020-08-07 |
2020-08-05 |
PlS
Planned sale
|
Chief Human Resources Officer
Officer
|
1,504
-61.3%
69.32
US$104,255
|
1,504
-61.3%
|
69.32
|
US$104,255
|
|
|
2020-07-15 |
2020-07-13 |
PlS
Planned sale
|
Chief Financial Officer
Officer
|
15,208
-83.3%
75.00
US$1,140,600
|
15,208
-83.3%
|
75.00
|
US$1,140,600
|
|
|
2020-06-19 |
2020-06-19 |
PlS
Planned sale
|
Non-Executive Director
|
881
-28.1%
64.42
US$56,750
|
881
-28.1%
|
64.42
|
US$56,750
|
|
|
2020-06-19 |
2020-06-19 |
PlS
Planned sale
|
Non-Executive Director
|
1,663
-34.6%
63.69
US$105,913
|
1,663
-34.6%
|
63.69
|
US$105,913
|
|
|
2020-06-11 |
2020-06-09 |
PlS
Planned sale
|
Chief Financial Officer
Officer
|
15,208
-45.4%
67.00
US$1,018,936
|
15,208
-45.4%
|
67.00
|
US$1,018,936
|
|
|
2020-05-28 |
2020-05-26 |
S
Sale
|
See Remarks
Officer
|
2,700
-94.6%
70.10
US$189,270
|
2,700
-94.6%
|
70.10
|
US$189,270
|
|
|
2020-05-20 |
2020-05-18 |
S
Sale
|
See Remarks
Officer
|
23,330
-99.3%
74.67
US$1,742,051
|
23,330
-99.3%
|
74.67
|
US$1,742,051
|
|
|
2020-05-13 |
2020-05-12 |
S
Sale
|
Non-Executive Director
|
1,295
-4.7%
79.17
US$102,522
|
1,295
-4.7%
|
79.17
|
US$102,522
|
|
|
2020-05-13 |
2020-05-12 |
S
Sale
|
Non-Executive Director
|
34,698
-55.6%
78.65
US$2,728,932
|
34,698
-55.6%
|
78.65
|
US$2,728,932
|
|
|
2020-05-13 |
2020-05-12 |
S
Sale
|
Non-Executive Director
|
13,024
-17.3%
77.71
US$1,012,138
|
13,024
-17.3%
|
77.71
|
US$1,012,138
|
|
|
2020-05-13 |
2020-05-12 |
S
Sale
|
Non-Executive Director
|
600
-0.8%
76.28
US$45,771
|
600
-0.8%
|
76.28
|
US$45,771
|
|
|
2020-05-13 |
2020-05-12 |
S
Sale
|
Non-Executive Director
|
1,350
-1.7%
75.43
US$101,833
|
1,350
-1.7%
|
75.43
|
US$101,833
|
|
|
2020-05-13 |
2020-05-12 |
S
Sale
|
Non-Executive Director
|
2,633
-3.3%
74.01
US$194,865
|
2,633
-3.3%
|
74.01
|
US$194,865
|
|
|
2020-05-13 |
2020-05-12 |
S
Sale
|
See Remarks
Officer
|
2,992
-95.1%
78.38
US$234,512
|
2,992
-95.1%
|
78.38
|
US$234,512
|
|
|
2020-05-13 |
2020-05-11 |
S
Sale
|
See Remarks
Officer
|
381
-10.8%
77.05
US$29,356
|
381
-10.8%
|
77.05
|
US$29,356
|
|
|
2020-04-29 |
2020-04-28 |
PlS
Planned sale
|
See Remarks
Executive Director
|
40,000
-3.7%
80.00
US$3,200,160
|
40,000
-3.7%
|
80.00
|
US$3,200,160
|
|
|
2020-04-29 |
2020-04-27 |
PlS
Planned sale
|
See Remarks
Executive Director
|
1,517
-0.1%
80.63
US$122,320
|
1,517
-0.1%
|
80.63
|
US$122,320
|
|
|
2020-04-29 |
2020-04-27 |
PlS
Planned sale
|
See Remarks
Executive Director
|
1,300
-0.1%
81.15
US$105,494
|
1,300
-0.1%
|
81.15
|
US$105,494
|
|
|
2020-04-22 |
2020-04-20 |
PlS
Planned sale
|
Chief Legal Officer
Officer
|
4,080
-35.4%
75.00
US$306,000
|
4,080
-35.4%
|
75.00
|
US$306,000
|
|
|
2020-03-17 |
2020-03-13 |
B
Purchase
|
Non-Executive Director
|
10,000
+46.7%
52.37
US$523,700
|
10,000
+46.7%
|
52.37
|
US$523,700
|
|
|
2020-03-09 |
2020-03-09 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
938
-26.5%
59.90
US$56,186
|
938
-26.5%
|
59.90
|
US$56,186
|
|
|
2020-03-09 |
2020-03-05 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
1,138
-30.5%
65.30
US$74,311
|
1,138
-30.5%
|
65.30
|
US$74,311
|
|
|
2020-02-20 |
2020-02-18 |
PlS
Planned sale
|
See Remarks
Executive Director
|
1,818
-0.2%
70.92
US$128,940
|
1,818
-0.2%
|
70.92
|
US$128,940
|
|
|
2020-02-20 |
2020-02-18 |
PlS
Planned sale
|
See Remarks
Executive Director
|
2,189
-0.2%
70.22
US$153,721
|
2,189
-0.2%
|
70.22
|
US$153,721
|
|
|
2020-02-20 |
2020-02-18 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
1,313
-33.6%
69.71
US$91,529
|
1,313
-33.6%
|
69.71
|
US$91,529
|
|
|
2020-02-10 |
2020-02-10 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
625
-19.4%
70.48
US$44,050
|
625
-19.4%
|
70.48
|
US$44,050
|
|
|
2020-02-10 |
2020-02-06 |
PlS
Planned sale
|
Chief Medical Officer
Officer
|
3,937
-60.3%
72.40
US$285,039
|
3,937
-60.3%
|
72.40
|
US$285,039
|
|
|
2020-02-04 |
2020-02-03 |
PlS
Planned sale
|
Chief Legal Officer
|
1,308
-10.2%
62.81
US$82,155
|
1,308
-10.2%
|
62.81
|
US$82,155
|
|
|
2020-02-04 |
2020-02-03 |
PlS
Planned sale
|
Chief Medical Officer
|
1,657
-20.2%
65.00
US$107,705
|
1,657
-20.2%
|
65.00
|
US$107,705
|
|
|
2020-02-04 |
2020-02-03 |
PlS
Planned sale
|
Chief Medical Officer
|
2,188
-25.1%
62.81
US$137,428
|
2,188
-25.1%
|
62.81
|
US$137,428
|
|
|
2020-01-29 |
2020-01-27 |
PlS
Planned sale
|
Chief Medical Officer
|
781
-27.9%
71.15
US$55,568
|
781
-27.9%
|
71.15
|
US$55,568
|
|
|
2020-01-23 |
2020-01-22 |
PlS
Planned sale
|
See Remarks
Executive Director
|
1,031
-0.1%
82.45
US$85,011
|
1,031
-0.1%
|
82.45
|
US$85,011
|
|
|
2020-01-23 |
2020-01-22 |
PlS
Planned sale
|
See Remarks
Executive Director
|
32,150
-2.9%
81.85
US$2,631,600
|
32,150
-2.9%
|
81.85
|
US$2,631,600
|
|
|
2020-01-23 |
2020-01-22 |
PlS
Planned sale
|
See Remarks
Executive Director
|
6,819
-0.6%
81.01
US$552,436
|
6,819
-0.6%
|
81.01
|
US$552,436
|
|
|
2020-01-23 |
2020-01-21 |
PlS
Planned sale
|
See Remarks
Executive Director
|
523
-0.0%
83.56
US$43,703
|
523
-0.0%
|
83.56
|
US$43,703
|
|
|
2020-01-23 |
2020-01-21 |
PlS
Planned sale
|
See Remarks
Executive Director
|
10,166
-0.9%
82.78
US$841,562
|
10,166
-0.9%
|
82.78
|
US$841,562
|
|
|
2020-01-23 |
2020-01-21 |
PlS
Planned sale
|
See Remarks
Executive Director
|
29,311
-2.6%
81.98
US$2,402,837
|
29,311
-2.6%
|
81.98
|
US$2,402,837
|
|
|
2020-01-03 |
2020-01-02 |
PlS
Planned sale
|
Chief Legal Officer
|
1,308
-13.5%
79.78
US$104,352
|
1,308
-13.5%
|
79.78
|
US$104,352
|
|
|
2019-12-13 |
2019-12-11 |
S
Sale
|
Pizzo Philip A.
Non-Executive Director
|
2,132
-100.0%
77.25
US$164,698
|
2,132
-100.0%
|
77.25
|
US$164,698
|
|
|
2019-12-13 |
2019-12-11 |
S
Sale
|
Pizzo Philip A.
Non-Executive Director
|
27,868
-92.9%
76.52
US$2,132,529
|
27,868
-92.9%
|
76.52
|
US$2,132,529
|
|
|
2019-12-11 |
2019-12-09 |
PlS
Planned sale
|
Lehrer-Graiwer Joshua
Chief Medical Officer
Officer
|
937
-100.0%
78.50
US$73,554
|
937
-100.0%
|
78.50
|
US$73,554
|
|
|
2019-12-09 |
2019-12-06 |
PlS
Planned sale
|
LOVE TED W
See Remarks.
Executive Director
|
3,716
-0.3%
76.15
US$282,973
|
3,716
-0.3%
|
76.15
|
US$282,973
|
|
|
2019-12-09 |
2019-12-06 |
PlS
Planned sale
|
LOVE TED W
See Remarks.
Executive Director
|
23,152
-2.1%
77.72
US$1,799,327
|
23,152
-2.1%
|
77.72
|
US$1,799,327
|
|
|
2019-12-09 |
2019-12-06 |
PlS
Planned sale
|
LOVE TED W
See Remarks.
Executive Director
|
6,800
-0.6%
76.78
US$522,122
|
6,800
-0.6%
|
76.78
|
US$522,122
|
|
|
2019-12-09 |
2019-12-06 |
PlS
Planned sale
|
LOVE TED W
See Remarks.
Executive Director
|
6,332
-0.6%
75.73
US$479,512
|
6,332
-0.6%
|
75.73
|
US$479,512
|
|
|
2019-12-09 |
2019-12-05 |
PlS
Planned sale
|
LOVE TED W
See Remarks.
Executive Director
|
6,750
-0.6%
75.39
US$508,873
|
6,750
-0.6%
|
75.39
|
US$508,873
|
|
|
2019-12-09 |
2019-12-05 |
PlS
Planned sale
|
LOVE TED W
See Remarks.
Executive Director
|
8,525
-0.7%
74.66
US$636,478
|
8,525
-0.7%
|
74.66
|
US$636,478
|
|
|
2019-12-09 |
2019-12-05 |
PlS
Planned sale
|
LOVE TED W
See Remarks.
Executive Director
|
996
-0.1%
74.08
US$73,784
|
996
-0.1%
|
74.08
|
US$73,784
|
|
|
2019-12-09 |
2019-12-05 |
PlS
Planned sale
|
LOVE TED W
See Remarks.
Executive Director
|
12,442
-1.1%
75.35
US$937,475
|
12,442
-1.1%
|
75.35
|
US$937,475
|
|
|
2019-12-09 |
2019-12-05 |
PlS
Planned sale
|
LOVE TED W
See Remarks.
Executive Director
|
11,287
-1.0%
74.62
US$842,262
|
11,287
-1.0%
|
74.62
|
US$842,262
|
|
|
2019-12-03 |
2019-12-02 |
PlS
Planned sale
|
SUVARI TRICIA BORGA
Chief Legal Officer
Officer
|
3,434
-33.7%
66.74
US$229,185
|
3,434
-33.7%
|
66.74
|
US$229,185
|
|
|
2019-11-27 |
2019-11-26 |
PlS
Planned sale
|
Chief Medical Officer
|
11,593
-100.0%
67.19
US$778,934
|
11,593
-100.0%
|
67.19
|
US$778,934
|
|
|
2019-11-27 |
2019-11-25 |
PlS
Planned sale
|
Chief Medical Officer
|
656
-100.0%
60.00
US$39,360
|
656
-100.0%
|
60.00
|
US$39,360
|
|
|
2019-11-27 |
2019-11-25 |
PlS
Planned sale
|
Chief Medical Officer
|
4,594
-100.0%
60.00
US$275,640
|
4,594
-100.0%
|
60.00
|
US$275,640
|
|
|
2019-11-27 |
2019-11-25 |
PlS
Planned sale
|
Chief Medical Officer
|
298
-100.0%
60.00
US$17,880
|
298
-100.0%
|
60.00
|
US$17,880
|
|
|
2019-11-27 |
2019-11-25 |
PlS
Planned sale
|
Chief Medical Officer
|
447
-100.0%
60.00
US$26,820
|
447
-100.0%
|
60.00
|
US$26,820
|
|
|
2019-11-27 |
2019-11-25 |
PlS
Planned sale
|
Chief Medical Officer
|
3,515
-100.0%
60.00
US$210,900
|
3,515
-100.0%
|
60.00
|
US$210,900
|
|
|
2019-11-27 |
2019-11-25 |
PlS
Planned sale
|
Chief Medical Officer
|
1,108
-100.0%
60.00
US$66,480
|
1,108
-100.0%
|
60.00
|
US$66,480
|
|
|
2019-11-27 |
2019-11-25 |
PlS
Planned sale
|
Chief Medical Officer
|
312
-100.0%
60.00
US$18,720
|
312
-100.0%
|
60.00
|
US$18,720
|
|
|
2019-11-20 |
2019-11-19 |
PlS
Planned sale
|
Chief Medical Officer
|
6,562
-100.0%
55.00
US$360,910
|
6,562
-100.0%
|
55.00
|
US$360,910
|
|
|
2019-11-20 |
2019-11-18 |
PlS
Planned sale
|
Chief Medical Officer
|
656
-100.0%
50.63
US$33,213
|
656
-100.0%
|
50.63
|
US$33,213
|
|
|
2019-11-18 |
2019-11-15 |
PlS
Planned sale
|
Lehrer-Graiwer Joshua
Chief Medical Officer
Officer
|
9,948
-100.0%
50.00
US$497,447
|
9,948
-100.0%
|
50.00
|
US$497,447
|
|
|
2019-11-18 |
2019-11-14 |
PlS
Planned sale
|
Lehrer-Graiwer Joshua
Chief Medical Officer
Officer
|
329
-100.0%
50.01
US$16,455
|
329
-100.0%
|
50.01
|
US$16,455
|
|
|
2019-11-05 |
2019-11-01 |
PlS
Planned sale
|
Chief Legal Officer
|
2,200
-17.8%
48.33
US$106,334
|
2,200
-17.8%
|
48.33
|
US$106,334
|
|
|
2019-11-05 |
2019-11-01 |
PlS
Planned sale
|
Chief Legal Officer
|
1,127
-8.3%
48.68
US$54,857
|
1,127
-8.3%
|
48.68
|
US$54,857
|
|
|
2019-10-10 |
2019-10-08 |
S
Sale
|
|
5,357
-100.0%
45.05
US$241,333
|
5,357
-100.0%
|
45.05
|
US$241,333
|
|
